Ignite Creation Date:
2025-12-24 @ 11:49 AM
Ignite Modification Date:
2026-01-03 @ 8:24 PM
Study NCT ID:
NCT03313661
Status:
UNKNOWN
Last Update Posted:
2018-08-27
First Post:
2017-10-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Co-administration of Cabergoline and Gliclazide Improve Glycemic Parameters and Lipid Profile in T2DM Patients
Sponsor:
Sherief Abd-Elsalam
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Diabetes Mellitus
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None